Login

Arun Jain, Chairman and CEO of Polaris Financial Technology Ltd., shares his views on ... 00:10:00

Share On Facebook Share On Twitter

Arun Jain, Chairman and CEO of Polaris Financial Technology Ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
ProMIS Neurosciences reckons it has the only assets to tackle - Eugene William , Promis Neurosciences Inc
00:10:00
Revolutionizing Graphite Production with Low-Cost, High-Quality Strategy
00:10:00
Addressing Mental Health in the Mining Industry: A Conversation with William Black
00:00:00
Imugene doses first patient in intravenous monotherapy arm of Phase 1 clinical trial - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:10:00
Invest in opportunities communities and people that are often overlooked|Marcos A. Rodriguez,CEO,Palladium Equity Partners
00:10:00
Customer Success Story | Robert Keane, CEO, Cimpress PLCCMPR:NSQ
00:10:00
Political Risks and Economic Booms: The Future of Infrastructure Investment | Gordon Bajnai, Chairman , Campbell Lutyens.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Moonfare's Co-Investment Strategy: Capitalizing on Private Equity Opportunities
00:10:00
"Navigating ECB Rate Cuts: Strategies for Investor Success"
00:10:00
Invests globally and has offices in California, Israel, India, and China|Nicholas Brathwaite,Founder and Managing Partner,Celesta (fka WRVI)
00:10:00
JC Penney's Fall from Retail Glory: A Tale of Decline

© 2017 - Neuhu+